<page><tag>3</tag><title>Genentech Posts 50 Percent Rise in Profit</title><text> NEW YORK (Reuters) - Genentech Inc. &amp;lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=DNA.N target=/stocks/quickinfo/fullquote"&amp;gt;DNA.N&amp;lt;/A&amp;gt; on Wednesday  posted a 50 percent rise in quarterly profit and raised its  full-year earnings forecast on strong sales of its new colon  cancer drug, sending its shares higher in after-hours trading.</text></page>